Literature DB >> 26141332

Peripheral Neuropathy: A Practical Approach to Diagnosis and Symptom Management.

James C Watson1, P James B Dyck2.   

Abstract

Peripheral neuropathy is one of the most prevalent neurologic conditions encountered by physicians of all specialties. Physicians are faced with 3 distinct challenges in caring for patients with peripheral neuropathy: (1) how to efficiently and effectively screen (in less than 2 minutes) an asymptomatic patient for peripheral neuropathy when they have a disorder in which peripheral neuropathy is highly prevalent (eg, diabetes mellitus), (2) how to clinically stratify patients presenting with symptoms of neuropathy to determine who would benefit from specialty consultation and what testing is appropriate for those who do not need consultation, and (3) how to treat the symptoms of painful peripheral neuropathy. In this concise review, we address these 3 common clinical scenarios. Easily defined clinical patterns of involvement are used to identify patients in need of neurologic consultation, the yield of laboratory and other diagnostic testing is reviewed for the evaluation of length-dependent, sensorimotor peripheral neuropathies (the most common form of neuropathy), and an algorithmic approach with dosing recommendations is provided for the treatment of neuropathic pain associated with peripheral neuropathy.
Copyright © 2015 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26141332     DOI: 10.1016/j.mayocp.2015.05.004

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  48 in total

1.  Quantitative Sensory Testing and Current Perception Threshold Testing in Patients With Chronic Pain Following Lower Extremity Fracture.

Authors:  Mari A Griffioen; Joel D Greenspan; Meg Johantgen; Kathryn Von Rueden; Robert V O'Toole; Susan G Dorsey; Cynthia L Renn
Journal:  Biol Res Nurs       Date:  2017-07-24       Impact factor: 2.522

Review 2.  Clinical effectiveness of low-level laser treatment on peripheral somatosensory neuropathy.

Authors:  Alireza Fallah; Alireza Mirzaei; Norbert Gutknecht; Amir Saberi Demneh
Journal:  Lasers Med Sci       Date:  2017-01-10       Impact factor: 3.161

3.  Ambulatory screening of diabetic neuropathy and predictors of its severity in outpatient settings.

Authors:  M S Qureshi; M Iqbal; S Zahoor; J Ali; M U Javed
Journal:  J Endocrinol Invest       Date:  2016-11-15       Impact factor: 4.256

Review 4.  Axon Transport and Neuropathy: Relevant Perspectives on the Etiopathogenesis of Familial Dysautonomia.

Authors:  Warren G Tourtellotte
Journal:  Am J Pathol       Date:  2015-12-24       Impact factor: 4.307

Review 5.  Capturing Novel Non-opioid Pain Targets.

Authors:  Clifford J Woolf
Journal:  Biol Psychiatry       Date:  2019-06-29       Impact factor: 13.382

6.  Glial-derived neurotrophic factor is essential for blood-nerve barrier functional recovery in an experimental murine model of traumatic peripheral neuropathy.

Authors:  Chaoling Dong; E Scott Helton; Ping Zhou; Xuan Ouyang; Xavier d'Anglemont de Tassigny; Alberto Pascual; José López-Barneo; Eroboghene E Ubogu
Journal:  Tissue Barriers       Date:  2018-09-05

7.  A rare case of long-term paraesthesia diagnosed as a paraneoplastic syndrome by anti-SOX1 antibody determination.

Authors:  Oriol Mirallas; Nuria Rial; Berta Martín-Cullell; Jesus Recio-Iglesias
Journal:  BMJ Case Rep       Date:  2019-07-16

Review 8.  A critical appraisal of the mild axonal peripheral neuropathy of late neurologic Lyme disease.

Authors:  Gary P Wormser; Franc Strle; Eugene D Shapiro; Raymond J Dattwyler; Paul G Auwaerter
Journal:  Diagn Microbiol Infect Dis       Date:  2016-11-12       Impact factor: 2.803

9.  Comparative Analysis of Chemotherapy-Induced Peripheral Neuropathy in Bioengineered Sensory Nerve Tissue Distinguishes Mechanistic Differences in Early-Stage Vincristine-, Cisplatin-, and Paclitaxel-Induced Nerve Damage.

Authors:  Kevin J Pollard; Brad Bolon; Michael J Moore
Journal:  Toxicol Sci       Date:  2021-02-26       Impact factor: 4.849

10.  Neuropathy target esterase (NTE/PNPLA6) and organophosphorus compound-induced delayed neurotoxicity (OPIDN).

Authors:  Rudy J Richardson; John K Fink; Paul Glynn; Robert B Hufnagel; Galina F Makhaeva; Sanjeeva J Wijeyesakere
Journal:  Adv Neurotoxicol       Date:  2020-03-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.